Is there an interaction between creatine and furosemide (Lasix)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Creatine and Furosemide Interaction

There is no direct pharmacological interaction between creatine supplementation and furosemide, but their concurrent use requires careful monitoring of renal function and hydration status, as both can independently affect kidney function and fluid balance.

Understanding the Theoretical Concerns

The concern about combining creatine and furosemide stems from their individual effects on renal function rather than a direct drug-drug interaction:

  • Creatine supplementation can cause transient water retention during early stages of use, which is the most common adverse effect 1
  • Furosemide is a loop diuretic that promotes fluid loss and can impair renal perfusion, particularly in volume-depleted states 2

When creatine is combined with other supplements or taken at higher than recommended doses for several months, there have been isolated cases of liver and renal complications, though these are not well-characterized 1

Key Clinical Considerations

Renal Function Monitoring

  • Furosemide can cause dose-dependent renal deterioration, particularly at doses ≥60 mg daily, with creatinine increases >0.3 mg/dL associated with nearly 3-fold higher mortality risk 3, 4
  • Patients on furosemide therapy should have serum creatinine and electrolytes checked 1-2 weeks after initiation, then every 1-2 weeks during dose titration 3
  • The combination theoretically increases the importance of monitoring, as both substances can affect renal parameters

Volume Status Management

  • Avoid furosemide in hypovolemic states, as it reduces renal perfusion and can cause azotemia 3, 4
  • Creatine causes early water retention, which could theoretically mask or complicate assessment of volume status in patients requiring diuretic therapy 1
  • Nonsteroidal anti-inflammatory agents should be avoided in patients with heart failure on furosemide, as they can block diuretic effects and cause sodium retention 2

Practical Management Algorithm

If a patient on furosemide wants to use creatine supplementation:

  • Ensure stable baseline renal function (creatinine <3 mg/dL, stable over recent weeks) 3
  • Use standard creatine dosing: loading with 0.3 g/kg/day for 5-7 days, then maintenance at 0.03 g/kg/day 1
  • Monitor weight daily, as patients on furosemide should already be doing this 2
  • Check creatinine and electrolytes 1-2 weeks after starting creatine, then monthly for the first 3 months 3
  • Adjust furosemide dose based on weight changes (increase of 1-2 kg may indicate need for supplemental diuretic dose) 2

If renal function deteriorates (creatinine increase >0.3 mg/dL):

  • Discontinue creatine supplementation first, as it is not medically necessary 4
  • Reassess volume status and furosemide dosing 2, 3
  • If volume overload persists despite rising creatinine, furosemide may need to be continued with close monitoring 3

Common Pitfalls to Avoid

  • Do not assume creatinine elevation is solely from furosemide if the patient is taking creatine—creatine supplementation itself can affect renal parameters 1
  • Do not use furosemide within 12 hours of starting creatine's loading phase, as the initial water retention from creatine could complicate volume assessment 5
  • Avoid high-dose furosemide (>60-80 mg) without careful justification in patients taking any supplements, as this significantly increases nephrotoxicity risk 3, 4

References

Research

Creatine supplementation.

Current sports medicine reports, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Furosemide and Albumin Use in Critical Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Furosemide-Associated Nephrotoxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Furosemide Administration in Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.